docetaxel,sotorasib
amgen
['docetaxel', 'sclc', 'lung', 'lcsm,(-blcsm)', 'nsclc', 'biomarker', 'codebreak 200', 'sotorasib']
#asco23 #lungcancer #lcsm md anderson cancer center
biomarker subgroup analyses of codebreak 200, a phase 3 trial of sotorasib vs docetaxel in patients w/ pretreated kras g12c-mutated advanced non-small cell lung cancer (nsclc) abstract: 9008 
Working to improve and save lives by funding groundbreaking research for the prevention, diagnosis, treatment and cure of lung cancer.